Publicaciones en las que colabora con Ana Cristina Riestra Ayora (17)

2019

  1. Galenic validation of plasma rich in growth factors eye drops

    Farmacia Hospitalaria, Vol. 43, Núm. 2, pp. 45-49

2018

  1. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

    Medicine (United States), Vol. 97, Núm. 17

  2. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops

    International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204

2017

  1. Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology

    Ocular Surface, Vol. 15, Núm. 2, pp. 248-256

  2. Silk fibroin films for corneal endothelial regeneration: Transplant in a rabbit descemet membrane endothelial keratoplasty

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 9, pp. 3357-3365

  3. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 391-399

2016

  1. Abnormal activity of corneal cold thermoreceptors underlies the unpleasant sensations in dry eye disease

    Pain, Vol. 157, Núm. 2, pp. 399-417

  2. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders

    Ophthalmic Research, Vol. 55, Núm. 2, pp. 53-61

  3. Human bone derived collagen for the development of an artificial corneal endothelial graft. in Vivo results in a rabbit model

    PLoS ONE, Vol. 11, Núm. 12

  4. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model

    Experimental Eye Research, Vol. 151, pp. 115-121

  5. Plasma rico en factores de crecimiento. Desarrollo y estandarización de su aplicación por vía oftálmica

    Plasma rico en factores de crecimiento. Desarrollo y estandarización de su aplicación por vía oftálmica

  6. Polymeric nanocapsules: a potential new therapy for corneal wound healing

    Drug Delivery and Translational Research, Vol. 6, Núm. 6, pp. 708-721

  7. Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye

    Ophthalmic Research, Vol. 56, Núm. 2, pp. 68-73

2015

  1. Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies

    Acta Ophthalmologica, Vol. 93, Núm. 8, pp. e605-e614

  2. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts

    Experimental Eye Research, Vol. 135, pp. 118-126

  3. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops after Their Different Time and Temperature Conditions of Storage

    Cornea, Vol. 34, Núm. 9, pp. 1144-1148

2014

  1. Manejo de endoftalmitis en cirugía de cataratas: guía terapéutica SECOIR-GESOC

    Mayo